Bacterial fimbriae mediate cell adhesion and are important in colonization. Fimbrial proteins from strains of Porphyromonas (Bacteroides) gingivalis isolated from different individuals were compared for their size, amino-terminal sequence, and antigenic diversity. Two major protein components of the crude fimbrial preparations differed in apparent molecular mass, ranging from 41 to 49 kDa for the fimbrillin monomer and from 61 to 78 kDa for the other major protein. The amino-terminal sequence of the antigenically related group of proteins of the fimbrillin monomer in the 41-to 49-kDa range showed significant homology; however, minor sequence heterogeneity was observed, mainly in residues 4 to 6. One of the observed amino-terminal sequences, AFGVGDDESKVAKLTVMVYNG, resembled the deduced sequence of P. gingivalis 381 (D. P. Dickinson, M. K. Kubiniec, F. Yoshimura, and R. J. Genco, J. Bacteriol. 170:1658-1665, 1988). Fimbriae from all the strains of P. gingivalis showing this sequence contained a fimbrillin monomer of 43 kDa and showed a strong reaction with both polyclonal and monoclonal antibodies directed to the fimbriae from P. gingivalis 2561 (381). Fimbriae from strains showing amino-terminal sequence variations in residues 4 to 6 (i.e., substitution of VGD with either E or NAG) were more diverse in their molecular sizes. Most of these variant fimbriae showed weak reactions with the polyclonal antibodies and no reaction with the monoclonal antibodies induced to the fimbriae of strain 2561. No correlation could be established between the molecular size and immunological reactivity of the fimbrillin monomer of P. gingivalis strains. Strains 9-14K-1 and HG 564 not only showed markedly different sequences from the other three amino-terminal sequences but also did not react with either polyclonal or monoclonal antibodies to the fimbriae of strain 2561. Strains W50, W83, and AJW 5 failed to show any immunological reactivity with the antibodies to fimbrillin or fimbriae of strain 2561. Fimbriae from different strains revealed different immunologic reactions with rabbit antisera to each of the synthetic peptides of residues 59-78 (peptide I), 79-100 (peptide J), and 91-108 (peptide E) of strain 381. These results suggest that P. gingivalis fimbrillin subunits have size, sequence, and antigenic heterogeneity among the strains and that these differences may be important in the function and immune reactivities of the fimbriae.
Several recent studies have implicated the black-pigmented gram-negative anaerobe Porphyromonas (Bacteroides) gingivalis in the pathogenesis of several oral diseases including periodontitis (30) , pulpal infections (10, 33) , and severe extraoral infections including tonsillar abscesses (3) . The first step in microbial colonization of oral surfaces involves the attachment or the adherence of bacteria to the teeth or oral epithelial surfaces. Numerous studies have established that major determinants of the adherence of bacteria to host surfaces are specific interactions mediated by macromolecules on the bacterial surface, called adhesins, that combine with complementary structures on host tissue surfaces (1, 8, 9, 13, 23) . Several observations suggest that these bacterial adhesins are frequently present in filamentous surface appendages called pili or fimbriae. Ultrastructural studies of different strains of P. gingivalis show the presence of fimbrialike structures (24, 25, 31, 34) . Recently, fimbriae have been purified from P. gingivalis 381, and it has been found that the fimbriae of this strain are polymers of repeated fimbrillin monomer subunits and that they have an approximate molecular mass of 43 kDa (35, 36) . The complete amino acid sequence was predicted from the cloned gene encoding the fimbrillin subunit (5) .
Monoclonal antibodies (MAbs) against purified fimbriae from strain 381 block the adherence of P. gingivalis to buccal epithelial cells (12) . The exact role of the fimbriae in the pathogenesis is not clear; however, adhesion of the bacteria to oral surfaces that is mediated by fimbriae or fimbriaassociated adhesins is likely to be important in colonization. Fimbriae from several pathogens are strongly antigenic (6, 7) and have been used to produce vaccines (17, 29) . P. gingivalis fimbrial adhesins are therefore attractive candidates for a vaccine. If the fimbrial protein is to be a practical P. gingivalis vaccine candidate, then at least some of the surface-exposed epitopes of this protein must be common to most of the strains of P. gingivalis. Suzuki and coworkers (32) suggested size and antigenic variation of the fimbrillin subunits from different strains of P. gingivalis. The present study was undertaken to examine the sizes, amino-terminal sequences, and antigenic diversity of the fimbrillin subunit proteins of P. gingivalis strains as a basis of understanding the role of this heterogeneity in fimbrial function and immune reactivity.
MATERIALS AND METHODS
Bacterial strains and culture conditions. The strains of P. gingivalis used in this study are shown in Table 1 . Most strains are from subgingival plaques of individual patients with periodontal disease, although some strains are from human saliva or infected human root canals. The strains represent a wide geographic distribution, with strains from three cities in the United States and from Germany, Japan, and The Netherlands. All strains of P. gingivalis were grown in half-strength (18.5 mg/ml) brain heart infusion broth Preparation and characterization of antisera. Polyclonal rabbit antibodies (PAbs) to fimbriae, fimbrillin, and synthetic peptides were prepared. The highly purified fimbriae of strain 2561 described above were used as the immunogen for the production of antifimbria antibodies. For the preparation of antibodies against the fimbrillin monomer, fimbriae were completely dissociated at 100°C in the presence of 1% SDS and 5% P-mercaptoethanol and then separated on a preparative SDS-polyacrylamide gel as described by Yoshimura and coworkers (36) . The fimbrillin band was eluted from the gel and used as the immunogen.
For the production of PAbs to synthetic peptides, each peptide was conjugated to thyroglobulin by using m-maleinimido benzoyl-N-hydroxysuccinimide ester (MBS) as a cross-linker, as described by Schmidt and coworkers (27) . Briefly, 10 mg of thyroglobulin, dissolved in 3 ml of phosphate-buffered saline (PBS) (pH 7.4), was activated by mixing with 5 mg of MBS in 1 ml of N,N-dimethylformamide. The solution was stirred for 2 h at room temperature, and unreacted MBS was removed by gel filtration on Sephadex G-25 in 0.1 M phosphate buffer, pH 6 .0. Synthetic peptides (5 mg each) were reduced with sodium borohydride, and excess borohydride was destroyed with acetic acid. The neutralized and reduced peptides were combined with MBS-activated thyroglobulin and stirred overnight at room temperature. The resulting peptide-carrier conjugate was subsequently isolated by gel filtration on Sephadex G-25 in 0.1 M ammonium bicarbonate buffer, pH 8.0.
New Zealand White rabbits (3 kg) were injected at multiple sites subcutaneously with 50 ,ug of the fimbriae or fimbrillin or with 500 ,ug of the appropriate conjugated peptide-carrier in complete Freund's adjuvant. Starting two weeks after the first injection, the rabbits were boosted weekly for four weeks with the respective immunogens in incomplete Freund's adjuvant. Six weeks after the first injection, each rabbit was bled and the antibodies were tested against the corresponding antigen by an enzymelinked immunosorbent assay (ELISA) and Western blotting. After the appropriate antibody titer was obtained, the rabbits were bled by heart puncture and the sera were prepared and stored at -20°C.
MAb production. MAbs to P. gingivalis 2561 fimbriae were generated by the procedure of Kohler and Milstein (15) as modified by McKearn (20) . The fimbriae, partially purified by chromatography on DEAE Sepharose CL-6B as described above, were used as the immunogen. Eight-week-old BALB/c mice were immunized subcutaneously with 100 pug of the fimbriae in complete Freund's adjuvant. The mice were boosted with the same amount of fimbriae in incomplete Freund's adjuvant three times at weekly intervals. Three days before sacrifice, the fimbriae in 0.1 M PBS (pH 7.2) were injected intraperitoneally into the mice. Spleen cells from the immunized mice were hybridized with SP 2/0 Ag-14 mouse myeloma cells by the procedure described previously (2) . Briefly, spleen cells and myeloma cells were mixed in a ratio of 1:0.2 and fused with polyethylene glycol 3400 at a final concentration of 50%. Hybrid cells surviving hypoxanthine-aminopteridine-thymidine nutritional selection were tested for antibody secretion by ELISA by using microtiter plates coated with 1 ,ug of the partially purified fimbriae per well. Positive clones were subcloned by limiting dilution at an average cell density of less than 1 The amino-terminal amino acid sequences of the fimbrillin subunit protein from different strains of P. gingivalis were determined in the gas-phase sequencer by the procedure described by Matsudaira (19) . Briefly, the crude fimbriae (0.5 mg of protein per gel), obtained by the ultrasonication procedure described above, were separated by preparative SDS-PAGE on the mini-gel system. The proteins were transferred onto polyvinylidene difluoride membranes (Immobilon; Millipore) on the PolyBlot transfer system for 40 min at 2.5 mA/cm2 of gel. After staining with 0.1% Coomassie brilliant blue for 2 min, the membranes were decolorized with destaining solution (60% methanol, 7% acetic acid). The membranes were washed twice with deionized water on a shaker for 10 min each. The fimbrillin bands were excised with a clean razor blade, dried, and then placed in the sequencer.
RESULTS
Molecular size of fimbriae. During the course of our study of the structure and function of P. gingivalis fimbriae, we found that fimbrial preparations from strain 2561 often contained two major protein components, a 43-kDa protein, which constitutes the major component of fimbriae, and a 75-kDa protein, as well as a few minor protein components. In order to compare the sizes and antigenic heterogeneity of the 43-kDa components, crude fimbrial extracts from different strains of P. gingivalis were subjected to SDS-PAGE. Figure 1 shows the SDS-polyacrylamide gel of a representative group of these strains, indicating the heterogeneity of size. There are two major bands for each strain; one is in the 41-to 49-kDa range, and another is in the 61-to 78-kDa range. We have successfully separated the 43-kDa fimbrial component from the higher-molecular-mass aggregate of strain 2561 Antigenic heterogeneity of fimbriae. In order to assess the antigenic heterogeneity of the fimbrillin components from different strains of P. gingivalis, PAbs raised against the 43-kDa fimbrillin (monomer) and fimbriae (polymer) and MAbs against the fimbriae of P. gingivalis 2561 were used. Antigens for the immunoblot analysis were prepared by heating the crude fimbrial preparations either at 100°C in the presence of P-mercaptoethanol to obtain the monomeric (completely dissociated) fimbrillin or at 80°C in the absence of ,3-mercaptoethanol to obtain the oligomeric (partially dissociated) fimbriae. The anti-fimbrillin PAbs reacted only with a single protein band appearing in the molecular mass range of 41 to 49 kDa of all strains of P. gingivalis tested. However, no immunoreactive band was observed for strains W50, W83, and AJW 5 ( Fig. 2A ; Table 2 ). The antifimbrillin PAbs did not react with oligomeric fimbriae. On the other hand, the PAbs to intact fimbriae reacted with oligomeric fimbriae from some but not all strains ( Fig. 2B ; Table 2 ). The MAb reacted with the oligomeric fimbriae of strains 2561, W, 1432, 1112, ESO 75, ESO 101, HG 565, AJW 2, A7A1-28, and A7A2-10 ( Fig. 2C ; Table 2 ). The MAbs did not show immunological cross-reactivity with other strains tested. These results suggest that considerable antigenic heterogeneity exists for the 41-to 49-kDa polymeric fimbriae of P. gingivalis.
Amino-terminal sequence of fimbriae. The sequences of the amino-terminal 20 residues of the immunoreactive 41-to 49-kDa protein bands were determined by solid-phase microsequencing. Proteins were separated on the SDS-polyacrylamide gels and electroblotted onto polyvinylidene difluoride membranes. The membranes were stained with Coomassie blue, and the fimbrillin bands in the 41-to 49-kDa range, previously shown to be immunoreactive with antifimbrillin PAbs, were used for amino acid sequence analysis. For the sake of comparison, different strains with identical amino-terminal sequences have been grouped together in Fig. 3 . The amino-terminal sequence of strain 381, obtained from the cloned gene, has been included in Fig. 3 for reference. Recent observation has suggested that strains 381 and 2561 are closely related, as they show similar restriction endonuclease patterns (18) . With the exception of strains 9-14K-1 and HG 564, all the strains tested showed sequence identity for the first three amino acids and then from amino acids 7 to 20. However, sequence heterogeneity exists from residues 4 to 6. The amino-terminal sequences of strains 9-14K-1 and HG 564 were more distinct, yet 12 of 20 residues were identical to the other strains (Fig. 3) . Although no immunologically reactive protein could be detected for strains W50, W83, and AJW 5, efforts were made to obtain the amino acid sequence of Coomassie blue-stained material in the 41-to 49-kDa range. None of these proteins from strain W50 showed amino-terminal sequence patterns similar to the fimbrial sequences of the other strains.
Reactivity of fimbriae with PAbs to synthetic peptides. PAbs to the synthetic peptides E, I, and J, representing residues in the stretch from 59 to 108 in the predicted fimbrillin sequence of strain 381 (5), were used for immunoblot analysis to determine whether heterogeneity exists in the internal region of the amino-terminal portion of the fimbrillin subunits. Figure 4 shows immunoreactivity of the anti-synthetic peptide antibodies with the 100°C-treated fimbriae from the representative strains of each group. Anti-synthetic peptide E (anti-E) recognized many of the strains tested but did not react with strains JKG 7, 9-14K-1, or HG 564. Anti-J also reacted with many of the strains tested, but not with strains AJW 4 c Reactivity of the polyclonal rabbit antiserum to the purified 43-kDa polymeric fimbriae from strain 2561 with partially dissociated oligomeric fimbriae (80°C; 5 min in the absence of ,3-mercaptoethanol).
d Reactivity of the MAb to the 43-kDa polymeric fimbriae from strain 2561 with partially dissociated oligomeric fimbriae.
e The anti-synthetic peptide antibodies were tested against completely dissociated fimbriae from the 24 strains tested. and AJW 5, even when a threefold excess of antigens or high concentrations of antibodies were used. This result is consistent with the observation by Suzuki and coworkers (32), who could not find any immunologically reactive fimbrial component in strain W83 and several other strains which were not tested in this study. In the case of W50, none of the Coomassie blue-stained bands around the 41-to 49-kDa range showed an amino-terminal sequence similar to the sequence observed for the other strains (data not shown). However, these strains appear to be sparsely fimbriated under an electron microscope (11, 21, 32; unpublished data), and it is not known whether these strains contain totally unrelated fimbrialike structures or whether they are too sparsely fimbriated to be detected by immunological techniques we used.
We have further expanded studies of the size and immunological heterogeneity of the strains of P. gingivalis on the basis of the amino acid sequences of the first 20 residues from different strains. Although all strains revealed considerable amino-terminal sequence homology, differences were observed. Fimbrillin subunits with identical molecular size generally showed identical sequences for the first 20 residues (Table 2 ). All the strains tested, with the exception of 9-14K-1 and HG 564 (Fig. 3) , had an Ala-Phe-Gly tripeptide as the first three residues and then either a deletion or a variation at positions 4 to 6, compared with the amino acid sequence of strain 381 (5) . The variable region is followed by a conserved segment of residues 7 to 20. Strains 9-14K-1 and HG 564 have a sequence for the first 20 amino acids that varies notably from the other strains. These observations reveal that with the exception of residues 4 to 6, much of the amino-terminal sequence is conserved in most of the strains of P. gingivalis. This pattern is similar to the conserved amino-terminal sequence heterogeneity observed for Neisseria gonorrhoeae (26, 28) , although no homology was found between P. gingivalis and the gonococci in the first 20 amino acids. Analysis of the entire amino acid sequence of fimbriae from representative strains of P. gingivalis will be necessary to establish whether there are discrete fimbrial types, as is only suggested by the results reported here.
It is interesting to note that all the strains showing aminoterminal sequence identity to strain 2561 not only have identical molecular size of the fimbrillin monomer but also show immunological cross-reactivity with MAbs raised against intact fimbriae of strain 2561. On the other hand, strains 9-14K-1 and HG 564 have a fimbrillin of 41 kDa which is not recognized either by MAbs and PAbs to intact fimbriae or by PAbs to synthetic peptide E, although PAbs to fimbrillin do recognize this protein. These two strains also have an identical amino-terminal sequence. In contrast, no clear-cut correlation could be established between size and immunological characteristics of the other strains.
Immunological differences observed among various strains by using PAbs and MAbs to fimbriae, as well as PAbs to synthetic peptides, suggest that fimbrillin proteins from different strains may have some structural or conformational differences. It should be noted that these peptides were derived from the amino-terminal one-third of the fimbrillin protein. The heterogeneity observed reflects diversity in this region; however, conformational alteration induced by variation at other sites cannot be ruled out from the present data. Additional information is needed to confirm this heterogeneity. In order to avoid any possibility that the apparent lack of cross-reactivity has resulted from conformational artifacts arising from the disaggregation methods employed, precaution was taken to treat fimbriae from all strains under identical conditions. Despite the marked antigenic, size, and sequence heterogeneity, there appear to be common epitopes among the fimbriae of P. gingivalis, as demonstrated by extensive cross-reactivity with PAbs to the fimbrillin monomer and with anti-E and anti-J peptide antibodies. Full evaluation of serotypes of P. gingivalis fimbriae requires testing a large battery of strains with antisera prepared against representative fimbriae from tentative clusters of strains, such as those identified by the present study. We are developing methods for the purification of intact fimbriae from different strains of P. gingivalis for such studies. Peptide mapping of fimbrillin and complete sequence analysis of fimbrillin genes from representative isolates of tentative strain clusters may also help in understanding the nature and basis of variation in fimbrillin monomers from P. gingivalis. P. gingivalis strains show variations in size, amino-terminal sequence, and antigenicity of fimbriae; however, the role of this variability in the function of the fimbriae is as yet unclear. Variation in antigenicity, for example, has been shown to be important in modulating the immune response to fimbriae from other organisms such as N. gonorrhoeae, and further experiments will be needed to determine if this is the case for P. gingivalis.
